Interaction between ciprofloxacin and rifampin

Annals of Pharmacotherapy

Volumn 33, Issue 7-8, 1999, Pages 868-870

  Temple, Mary E ^a   Nahata, Milap C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PEFLOXACIN; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; DRUG EFFECT; DRUG SCREENING; HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 0032783172     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18392     Document Type: Article

References (24)

1. Rubin J, Stoehr G, Yu VL, Muder RR, Matador A, Kamerer DB. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg 1989;115:1063-9.
2. Desplaces N, Gutmann L, Carlet J, Guibert J, Acar JF. The new quinolones and their combinations with other agents for therapy of severe infections. J Antimicrob Chemother 1986;17(suppl):25-39.
3. Norden CW, Fierer J, Bryant RE. Chronic staphylococcal osteomyelitis: treatment with regimens containing rifampin. Rev Infect Dis 1983;5(suppl): 495-501.
4. Crump B, Wise R, Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 1983;24:784-6.
5. Wingender W, Graefe KH, Gau W, Forster D, Berrmann D, Schacht P. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. Eur J Clin Microbiol Infect Dis 1984;3:355-9.
6. Barriere SL, Kaatz GW, Seo SM. Rifampin drug interactions. Antimicrob Agents Chemother 1989;33:589-90.
7. Henry NK, Rouse MS, Whitesell AL, Metal ME, Wilson WR. Treatment of methicillin resistant Staphylococcus aureus experimental osteomyelitis with ofloxacin or vancomycin alone or in combination with rifampin. Am J Med 1987;82(suppl 4A):73-5.
8. Chandler MH, Toler SM, Rapp RP, Muder RR, Korvick JA. Multiple dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients. Antimicrob Agents Chemother 1990;34:442-7.
9. Weinstein MP, Deeter RG, Swanson KA, Gross JS. Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers. Antimicrob Agents Chemother 1991;35:2352-8.
10. Mandell GL. The antimicrobial activity of rifampin with emphasis on the relation to phagocytes. Rev Infect Dis 1983;5(suppl):S463-7.
11. Acocella G. Pharmacokinetics and metabolism of rifampicin in humans. Rev Infect Dis 1983;5(suppl):S428-32.
12. Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med 1989;87(suppl 5A):76S-80S.
13. Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 1989;36:39-46.
14. Herbert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992; 52:453-7.
15. Reichel C, Block W, Skodra T, Traber F, Schiedermaier P, Spengler U, et al. Relationship between cytochrome P-450 induction by rifampicin, hepatic volume and portal blood flow in man. Eur J Gastroenterol Hepatol 1997;9:975-9.
16. Kovacs SJ, Martin DE, Everitt DE, Patterson SD, Jorkasky DK. Urinary excretion of 6 beta hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations. Clin Pharmacol Ther 1998; 63:617-22.
17. Barriere SL, Kaatz GW, Seo SM. Enhanced elimination of ciprofloxacin after multiple dose administration of rifampin to rabbits. Antimicrob Agents Chemother 1989;33:589-90.
18. Barriere SL, Kaatz GW, Schaberg DR, Fekety R. Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits. Antimicrob Agents Chemother 1987;31:1075-8.
19. LeBel M, Vallee F, Bergeron M. Tissue penetration of ciprofloxacin after single and multiple doses. Antimicrob Agents Chemother 1986;29: 501-5.
20. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right sided endocarditis in intravenous drug users with ciprofloxacin and rifampin. Lancet 1989;2:1071-3.
21. Schrenzel J, Dayer P, Leemann T, Weidekamm E, Portmann R, Lew DP. Influence of rifampin on fleroxacin pharmacokinetics. Antimicrob Agents Chemother 1993;37:2132-8.
22. Hackbarth CJ, Chambers HF, Sande MA. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against S. aureus. Antimicrob Agents Chemother 1986;29:611-3.
23. Palmer SM, Rybak MJ. Pharmacodynamics of once or twice daily levofloxacin versus vancomycin, with or without rifampin, against S. aureus in an in vitro model with infected platelet fibrin clots. Antimicrob Agents Chemother 1996;40:701-5.
24. Kaatz G, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental S. aureus endocarditis. Antimicrob Agents Chemother 1989;33:1184-7.